MCM
TMO icon

Manchester Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Manchester Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$975K Sell
1,984
-28
-1% -$15.2K 0.14% 95
2025
Q4 		$1.17M Buy
2,012
+101
+5% +$57.1K 0.16% 87
2025
Q3 		$927K Sell
1,911
-397
-17% -$185K 0.13% 113
2025
Q2 		$936K Buy
2,308
+41
+2% +$17.1K 0.12% 130
2025
Q1 		$1.13M Buy
2,267
+32
+1% +$17.3K 0.14% 101
2024
Q4 		$1.16M Sell
2,235
-920
-29% -$506K 0.14% 99
2024
Q3 		$1.95M Sell
3,155
-62
-2% -$36.7K 0.23% 66
2024
Q2 		$1.78M Buy
3,217
+26
+0.8% +$14.9K 0.21% 66
2024
Q1 		$1.85M Buy
3,191
+121
+4% +$67.9K 0.23% 66
2023
Q4 		$1.63M Sell
3,070
-200
-6% -$96.8K 0.22% 69
2023
Q3 		$1.66M Sell
3,270
-183
-5% -$97.5K 0.25% 60
2023
Q2 		$1.8M Sell
3,453
-595
-15% -$321K 0.24% 61
2023
Q1 		$2.33M Buy
4,048
+2
+0% +$1.13K 0.31% 46
2022
Q4 		$2.23M Buy
4,046
+1,041
+35% +$552K 0.33% 41
2022
Q3 		$1.52M Hold
3,005
– – 0.27% 55
2022
Q2 		$1.63M Hold
3,005
– – 0.28% 55
2022
Q1 		$1.77M Sell
3,005
-10
-0.3% -$5.74K 0.26% 58
2021
Q4 		$2.01M Buy
3,015
+30
+1% +$18.7K 0.26% 51
2021
Q3 		$1.71M Buy
2,985
+29
+1% +$15.9K 0.23% 61
2021
Q2 		$1.49M Sell
2,956
-140
-5% -$66.1K 0.21% 74
2021
Q1 		$1.41M Sell
3,096
-688
-18% -$328K 0.21% 77
2020
Q4 		$1.76M Buy
3,784
+30
+0.8% +$14.1K 0.27% 52
2020
Q3 		$1.66M Sell
3,754
-1,039
-22% -$429K 0.26% 52
2020
Q2 		$1.74M Hold
4,793
– – 0.24% 48
2020
Q1 		$1.36M Sell
4,793
-63
-1% -$19.9K 0.22% 54
2019
Q4 		$1.58M Hold
4,856
– – 0.17% 64
2019
Q3 		$1.41M Hold
4,856
– – 0.17% 66
2019
Q2 		$1.43M Sell
4,856
-556
-10% -$153K 0.18% 64
2019
Q1 		$1.48M Sell
5,412
-1,038
-16% -$258K 0.19% 58
2018
Q4 		$1.34M Hold
6,450
– – 0.2% 53
2018
Q3 		$1.57M Hold
6,450
– – 0.23% 45
2018
Q2 		$1.34M Sell
6,450
-495
-7% -$105K 0.2% 53
2018
Q1 		$1.43M Sell
6,945
-640
-8% -$134K 0.23% 44
2017
Q4 		$1.44M Hold
7,585
– – 0.21% 45
2017
Q3 		$1.44M Hold
7,585
– – 0.22% 41
2017
Q2 		$1.32M Sell
7,585
-40
-0.5% -$6.72K 0.21% 43
2017
Q1 		$1.17M Sell
7,625
-125
-2% -$19.1K 0.19% 47
2016
Q4 		$1.09M Hold
7,750
– – 0.17% 50
2016
Q3 		$1.23M Hold
7,750
– – 0.19% 48
2016
Q2 		$1.15M Sell
7,750
-100
-1% -$14.8K 0.16% 55
2016
Q1 		$1.11M Sell
7,850
-164
-2% -$22K 0.15% 60
2015
Q4 		$1.14M Buy
8,014
+460
+6% +$61.4K 0.16% 61
2015
Q3 		$924K Hold
7,554
– – 0.15% 54
2015
Q2 		$980K Buy
7,554
+3,135
+71% +$409K 0.16% 57
2015
Q1 		$593K Sell
4,419
-1,208
-21% -$156K 0.09% 94
2014
Q4 		$705K Hold
5,627
– – 0.09% 102
2014
Q3 		$685K Sell
5,627
-163
-3% -$19.8K 0.09% 97
2014
Q2 		$683K Hold
5,790
– – 0.09% 110
2014
Q1 		$696K Hold
5,790
– – 0.11% 101
2013
Q4 		$645K Hold
5,790
– – 0.1% 112
2013
Q3 		$534K Sell
5,790
-77
-1% -$6.96K 0.09% 120
2013
Q2 		$497K Buy
+5,867
New +$488K 0.09% 119

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Manchester Capital Management's TMO Position: Q1 2026 in Review

Manchester Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 1.4% in Q1 2026, selling an estimated $15.2K and leaving 1,984 shares worth $975K. The position accounts for 0.14% of the portfolio, ranked #95.

Manchester Capital Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.33M in Q1 2023. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Manchester Capital Management held 1,984 shares of Thermo Fisher Scientific worth $975K as of Q1 2026.
  • Manchester Capital Management sold 28 Thermo Fisher Scientific shares in Q1 2026, an estimated $15.2K.
  • Thermo Fisher Scientific made up 0.14% of Manchester Capital Management's portfolio in Q1 2026, its #95 holding.
  • Manchester Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Manchester Capital Management's Thermo Fisher Scientific position peaked at $2.33M in Q1 2023.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.